MedTrace Logo

The Benefits of Hippotherapy for Patients With Parkinson's Disease of 75 Years

NCT06500182 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2024-07-17

No results posted yet for this study

Summary

There is no cure for Parkinson's disease, resulting in an interest for research in this domain. Non pharmacological measures remain essential, specifically physical activity. Hippotherapy is a nonconventional method which uses the horse in addition to standard care. The goal being to improve or maintain the gains of the person through cognitive, sensorial and motor stimulation, with the aim of improving quality of life and maintaining independence. With this in mind, the researchers propose to evaluate quality of life as the main criterion, using the PDQ8 scale validated for this disease. The researchers hope results will lead to the coverage of the costs of non-conventional therapies such as hippotherapy by social security services.

Conditions

  • Parkinson Disease

Interventions

OTHER

hippotherapy sessions

Patients benefit from the hippotherapy sessions in additional to continuing to receive traditional care.

Sponsors & Collaborators

  • Central Hospital Saint Quentin

    lead OTHER_GOV

Principal Investigators

  • Jadwiga ATTIER, PHD · CH SAINT-QUENTIN

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2024-07-31
Completion
2024-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06500182 on ClinicalTrials.gov